Cartesian Therapeutics(RNAC) - Prospectus(update)

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on September 9, 2024 Registration No. 333-281204 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cartesian Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 26-1622110 (I.R.S. ...